Emerging neuroprotective strategies for Alzheimer's disease: Dietary restriction, telomerase activation, and stem cell therapy

Experimental Gerontology

Volumn 35, Issue 4, 2000, Pages 489-502

  Mattson, M P ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Amyloid; BDNF; Calorie; Deoxyglucose; Huntington; Parkinson; Stem cells; Stroke; Telomerase reverse transcriptase

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; DEOXYGLUCOSE; PRESENILIN 1; PRESENILIN 2; TELOMERASE;

ALZHEIMER DISEASE; APOPTOSIS; CALCIUM HOMEOSTASIS; DEGENERATIVE DISEASE; DIET RESTRICTION; ENERGY METABOLISM; ENZYME ACTIVATION; HUNTINGTON CHOREA; NERVE CELL DEGENERATION; NEUROPROTECTION; OUTCOMES RESEARCH; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; STROKE;

ALZHEIMER DISEASE; ENZYME ACTIVATION; HUMANS; NEUROLOGY; STEM CELL TRANSPLANTATION; TELOMERASE;

EID: 0034233456     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(00)00115-7     Document Type: Review

References (99)

1. Ancolio K., Marambaud P., Dauch P., Checler F. Alpha-secretase-derived product of β-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J. Neurochem. 69:1997;2494-2499.
2. Begley J.G., Duan W., Duff K., Mattson M.P. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72:1999;1030-1039.
3. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
4. Bozner P., Grishko V., LeDoux S.P., Wilson G.L., Chyan Y.C., Pappolla M.A. The amyloid beta protein induces oxidative damage of mitochondrial DNA. J. Neuropathol. Exp. Neurol. 56:1997;1356-1362.
5. Bruce-Keller A.J., Umberger G., McFall R., Mattson M.P. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45:1999;8-15.
6. Busser J., Geldmacher D.S., Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J. Neurosci. 18:1998;2801-2807.
7. Butterfield, D.A., Stadtman, E.R., 1997. Protein oxidation processes in aging brain. In: Mattson, M.P., Geddes, J.W. (Eds.), The Aging Brain. JAI Press, Greenwich, CT. Adv. Cell Aging Gerontol. 2, 161-191.
8. Butterfield D.A., Hensley K., Harris M., Mattson M.P., Carney J. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:1994;710-715.
9. Cefalu W.T., Wagner J.D., Wang Z.Q., Bell-Farrow A.D., Collins J., Haskell D., Bechtold R., Morgan T. A study of caloric restriction and cardiovascular aging in cynomolgus monkeys (Macaca fascicularis): a potential model for aging research. J. Gerontol. A Biol. Sci. Med. Sci. 52:1997;B10-B19.
10. Chan S.L., Griffin W.S.T., Mattson M.P. Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and in Alzheimer's disease. J. Neurosci. Res. 57:1999;315-323.
11. Chan S.L., Mayne M., Holden C.P., Geiger J.D., Mattson M.P. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J. Biol. Chem. 295:2000;18 195-18 200.
12. DeKosky S.T., Scheff S.W., Styren S.D. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration. 5:1996;417-421.
13. Duan W., Mattson M.P. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57:1999;195-206.
14. Duan W., Rangnekar V.M., Mattson M.P. Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J. Neurochem. 72:1999;2312-2322.
15. Dubey A., Forster M.J., Lal H., Sohal R.S. Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of mouse. Arch. Biochem. Biophys. 333:1996;189-197.
16. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., Gage F.H. Neurogenesis in the adult human hippocampus. Nature Med. 4:1998;1313-1317.
17. Ferrer I., Marin C., Rey M.J., Ribalta T., Goutan E., Blanco R., Tolosa E., Marti E. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J. Neuropathol. Exp. Neurol. 58:1999;729-739.
18. Fu W., Begley J.G., Killen M.W., Mattson M.P. Anti-apoptotic role of telomerase in pheochromocytoma cells. J. Biol. Chem. 274:1999;7264-7271.
19. Fu W., Killen M., Pandita T., Mattson M.P. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J. Mol. Neurosci. 14:2000;3-15.
20. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature. 379:1996;74-78.
21. Furukawa K., Sopher B., Rydel R.E., Begley J.G., Martin G.M., Mattson M.P. Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted APP is conferred by a C-terminal heparin-binding domain. J. Neurochem. 67:1996;1882-1896.
22. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 373:1995;523-527.
23. Gibson G.E., Sheu K.F., Blass J.P. Abnormalities of mitochondrial enzymes in Alzheimer disease. J. Neural. Transm. 105:1998;855-870.
24. Good P.F., Werner P., Hsu A., Olanow C.W., Perly D.P. Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28.
25. Goodman Y., Mattson M.P. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128:1994;1-12.
26. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
27. Grant W. Dietary links to Alzheimer's disease. Alz. Dis. Rev. 2:1997;42-55.
28. Greider C.W. Telomerase activity, cell proliferation, and cancer. Proc. Natl. Acad. Sci. USA. 95:1998;90-92.
29. Grynspan F., Griffin W.R., Cataldo A., Katayama S., Nixon R.A. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res. 763:1997;145-158.
30. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Martin G.M., Mattson M.P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. NeuroReport. 8:1996;379-383.
31. Guo G., Sopher B.L., Pham D.G., Furukawa K., Robinson N., Martin G.M., Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17:1997;4212-4222.
32. Guo Q., Christakos S., Robinson N., Mattson M.P. Calbindin blocks the pro-apoptotic actions of mutant presenilin-1: reduced oxidative stress and preserved mitochondrial function. Proc. Natl. Acad. Sci. USA. 95:1998;3227-3232.
33. Guo Q., Fu W., Xie J., Luo H., Sells S.F., Geddes J.W., Bondada V., Rangnekar V.M., Mattson M.P. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Nature Med. 4:1998;957-962.
34. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., Mattson M.P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knockin mice. Nature Med. 5:1999a;101-107.
35. Guo Q., Sebastian L., Sopher B.L., Miller M.W., Glazner G.W., Ware C.B., Martin G.M., Mattson M.P. Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a presenilin-1 mutation. Proc. Natl. Acad. Sci. USA. 96:1999b;4125-4130.
36. Guo Q., Fu W., Sopher B.L., Holtsberg F.W., Steiner S.M., Mattson M.P. Superoxide mediates the apoptosis-enhancing action of presenilin-1 mutations. J. Neurosci. Res. 56:1999c;457-470.
37. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
38. Harley C.B. Telomere loss: mitotic clock or genetic time bomb? Mutat. Res. 256:1991;271-282.
39. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya S., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
40. Ingram D.K., Weindruch R., Spangler E.L., Freeman J.R., Walford R.L. Dietary restriction benefits learning and motor performance of aged mice. J. Gerontol. 42:1987;78-81.
41. Johansson C.B., Svensson M., Wallstedt L., Janson A.M., Frisen J. Neural stem cells in the adult human brain. Exp. Cell Res. 253:1999;733-736.
42. Karlseder J., Broccoli D., Dal Y., Hardy S., de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 283:1999;1321-1325.
43. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology. 43:1993;13-20.
44. +-ATPase activity, glucose transport and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res. 50:1997;522-530.
45. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G., Mattson M.P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:1997;273-284.
46. Keller J.N., Guo Q., Holtsberg F.W., Bruce-Keller A.J., Mattson M.P. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18:1998;4439-4450.
47. Kelliher M., Fastbom J., Cowburn R.F., Bonkale W., Ohm T.G., Ravid R., Sorrentino V., O'Neill C. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies. Neuroscience. 92:1999;499-513.
48. Kurumatani T., Fastbom J., Bonkale W.L., Bogdanovic N., Winblad B., Ohm T.G., Cowburn R.F. Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology. Brain Res. 796:1998;209-221.
49. Lane M.A., Baer D.J., Rumpher W.V., Weindruch R., Ingram D.K., Tilmont E.M., Cutler R.G., Roth G.S. Calorie restriction lowers body temperature in rhesus monkeys, consistent with a postulated anti-aging mechanism in rodents. Proc. Natl. Acad. Sci. USA. 93:1996;4159-4164.
50. Lane M.A., Ingram D.K., Roth G.S. 2-Deoxy-D-glucose feeding in rats mimics physiologic effects of calorie restriction. J. Anti-Aging Med. 1:1998;327-337.
51. Lannfelt L., Basun H., Wahlund L.O., Rowe B.A., Wagner S.L. Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nature Med. 1:1995;829-832.
52. Larson J., Lynch G., Games D., Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840:1999;23-35.
53. Lee J., Bruce-Keller A.J., Kruman Y., Chan S.L., Mattson M.P. 2-deoxy-D-glucose protects hippocampal neurons against excitotoxic and oxidative injury: evidence for the involvement of stress proteins. J. Neurosci. Res. 57:1999;48-61.
54. Lee, J., Duan, W., Long, J.M., Ingram, D.K., Mattson, M.P., 2000. Dietary restriction increases survival of newly-generated neural cells and induces BDNF expression in the dentate gyrus of rats. J. Mol. Neurosci. (in press).
55. Li H., Cao Y., Berndt M.C., Funder J.W., Liu J.P. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro. Oncogene. 18:1999;6785-6794.
56. Liu J.P. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 13:1999;2091-2104.
57. Logroscino G., Marder K., Cote L., Tang M.X., Shea S., Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann. Neurol. 39:1996;89-94.
58. Lovell M.A., Ehmann W.D., Mattson M.P., Markesbery W.R. Elevated 4-hydroxynonenal levels in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18:1997;457-461.
59. 2+ homeostasis and cell death. J. Neurosci. 15:1995;6239-6249.
60. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264.
61. Mark R.J., Pang Z., Geddes J.W., Mattson M.P. Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17:1997;1046-1054.
62. Mattson M.P. Cellular actions of β-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives. Physiol. Rev. 77:1997;1081-1132.
63. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21:1998;53-57.
64. Mattson M.P. Hoff P.R., Mobbs C.V. Functional Neurobiology of Aging. 2000;Academic Press, San Diego, CA. (in press).
65. Mattson M.P., Guo Q. The presenilins. The Neuroscientist. 5:1998;112-124.
66. Mattson M.P., Linvall O. Neurotrophic factors and the aging brain. Mattson M.P., Geddes J.W. The Aging Brain: Advances in Cell Aging and Gerontology. vol. 2:1997;299-345 JAI Press, Greenwich, CT.
67. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
68. Mattson M.P., Cheng B., Culwell A., Esch F., Lieberburg I., Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron. 10:1993;243-254.
69. Mattson M.P., Barger S.W., Furukawa K., Bruce A.J., Wyss-Coray T., Mark R.J., Mucke L.S. Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease. Brain Res. Rev. 23:1997a;47-61.
70. Mattson M.P., Fu W., Waeg G., Uchida K. 4-hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. NeuroReport. 8:1997b;2275-2281.
71. Mattson M.P., Robinson N., Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. NeuroReport. 8:1997c;3817-3821.
72. Mattson M.P., Partin J., Begley J.G. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites. Brain Res. 807:1998;167-176.
73. Mattson M.P., Pedersen W.A., Duan W., Culmsee C., Camandola S. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Ann. N.Y. Acad. Sci. 893:1999;154-175.
74. Mattson M.P., Guo Z.H., Geiger J.D. Secreted form of amyloid precursor protein attenuates oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J. Neurochem. 73:1999;532-537.
75. Mattson M.P., Chan S.L., LaFerla F.M., Leissring M.A., Shepel P.N., Geiger J.D. Endoplasmic reticulum calcium signaling in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23:2000a;222-229.
76. Mattson M.P., Culmsee C., Yu Z., Camandola S. Roles of NF-κB in neuronal survival and plasticity. J. Neurochem. 74:2000b;443-456.
77. Mayeux R., Costa R., Bell K., Merchant C., Tung M.X., Jacobs D. Reduced risk of Alzheimer's disease among individuals with low calorie intake. Neurology. 59:1999;S296-S297.
78. McDonald J.W., Liu X.Z., Qu Y., Liu S., Mickey S.K., Turetsky D., Gottlieb D.I., Choi D.W. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nature Med. 5:1999;1410-1412.
79. Molchan S.E., Hill J.L., Mellow A.M., Lawlor B.A., Martinez R., Sunderland T. The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines. Int. Psychogeriatr. 2:1990;99-122.
80. Palmer T.D., Markakis E.A., Willhoite A.R., Sfar F., Gage F.H. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J. Neurosci. 19:1999;8487-8497.
81. Pappolla M.A., Chyan Y.J., Omar R.A., Hsiao K., Perry G., Smith M.A., Bozner P. Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol. 152:1998;871-877.
82. Parent A., Linden D.J., Sisodia S.S., Borchelt D.R. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis. 6:1999;56-62.
83. Pedersen W.A., Culmsee C., Ziegler D., Herman J.P., Mattson M.P. Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease. J. Mol. Neurosci. 13:1999;159-165.
84. Rhyu M.S. Telomeres, telomerase and immortality. J. Natl. Cancer Inst. 87:1995;884-894.
85. Scheffler B., Horn M., Blumcke I., Laywell E.D., Coomes D., Kukekov V.G., Steindler D.A. Marrow-mindedness: a perspective on neuropoiesis. Trends Neurosci. 22:1999;348-357.
86. Sheu K.F., Cooper A.J., Koike K., Koike M., Lindsay J.G., Blass J.P. Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann. Neurol. 35:1994;312-318.
87. Snowdon D.A., Kemper S.J., Mortimer J.A., Greiner L.H., Wekstein D.R., Markesbery W.R. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun study. JAMA. 275:1996;528-532.
88. Snyder E.Y., Yoon C., Flax J.D., Macklis J.D. Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc. Natl. Acad. Sci. USA. 94:1997;11,663-11,668.
89. Sohal R.S., Weindruch R. Oxidative stress, caloric restriction, and aging. Science. 273:1996;59-63.
90. Stewart J., Mitchell J., Kalant N. The effects of life-long food restriction on spatial memory in young and aged Fischer 344 rats measured in the eight-arm radial and the Morris water mazes. Neurobiol. Aging. 10:1989;669-675.
91. Studer L., Tabar V., McKay R.D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1:1998;290-295.
92. Svendsen C.N., Smith A.G. New prospects for human stem-cell therapy in the nervous system. Trends Neurosci. 22:1999;357-364.
93. Vanhanen M., Soininen H. Glucose intolerance, cognitive impairment and Alzheimer's disease. Curr. Opin. Neurol. 11:1998;673-677.
94. Vescovi A.L., Snyder E.Y. Establishment and properties of neural stem cell clones: plasticity in vitro and in vivo. Brain Pathol. 9:1999;569-598.
95. Weiss S., Reynolds B.A., Vescovi A.L., Morshead C., Craig C.G., van der Kooy D. Is there a neural stem cell in the mammalian forebrain. Trends Neurosci. 19:1996;387-393.
96. Xiao J., Perry G., Troncoso J., Monteiro M.J. Alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;954-963.
97. Yu Z.F., Mattson M.P. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 57:1999;830-839.
98. Zhu H., Guo Q., Mattson M.P. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res. 842:1999;224-229.
99. Zhu, H., Fu, W., Mattson, M.P., 2000. The catalytic subunit of telomerase protects neurons against amyloid β-peptide-induced apoptosis. J. Neurochem. 75, 117-124.